To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: CHDDT
Cardiovascular & Hematological Disorders-Drug Targets
ISSN: 1871-529X (Print)
eISSN: 2212-4063 (Online)
Aims and Scope:Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Editor-in-Chief:
Pietro Scicchitano Department of Cardiology
Hospital "F. Perinei"
Bari
Italy
Hospital "F. Perinei"
Bari
Italy
Indexed in:
Portico, Scopus, EMBiology, OpenAire, Index Medicus, MEDLINE/PubMed, Cambridge Scientific Abstracts (CSA)/ProQuest, BIOSIS Reviews Reports and Meetings, BIOSIS Previews, Ulrich's Periodicals Directory, Suweco CZ, Scilit, QOAM, PubsHub, Norwegian Register, MediaFinder®-Standard Periodical Directory, JournalTOCs, J-Gate, Google Scholar, Genamics Journal Seek, EMBASE, EBSCO, Jisc (Formerly: SHERPA/RoMEO), Dimensions, CNKI Scholar, Chemical Abstracts Service/SciFinder, Cabell's Directory/Journalytics, British Library... View all
Special Issues With Active Call for Papers
Submission closes on: May 21, 2026
Innovative Approaches for Monitoring Cardiological and Hematological Patients
In recent years, the scientific community has become particularly interested in the frontier areas of medical science: telemedicine, big data, artificial intelligence, and biomarkers. At the same time, an interdisciplinary approach in cardiology and hematology is of great importance, given the increasing importance of multimorbidity with the advent of new therapeutic methods for chronic non-communicable diseases. The purpose of this issue was the authors' attempt to reveal the importance of an interdisciplinary approach in cardiology... see more